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Recent studies have shown that the genes of the gibberellin (GA)
biosynthesis pathway in the fungus Gibberella fujikuroi are orga-
nized in a cluster of at least seven genes. P450–1 is one of four
cytochrome P450 monooxygenase genes in this cluster. Disruption
of the P450–1 gene in the GA-producing wild-type strain IMI 58289
led to total loss of GA production. Analysis of the P450–1-disrupted
mutants indicated that GA biosynthesis was blocked immediately
after ent-kaurenoic acid. The function of the P450–1 gene product
was investigated further by inserting the gene into mutants of G.
fujikuroi that lack the entire GA gene cluster; the gene was highly
expressed under GA production conditions in the absence of the
other GA-biosynthesis genes. Cultures of transformants contain-
ing P450–1 converted ent-[14C]kaurenoic acid efficiently into
[14C]GA14, indicating that P450–1 catalyzes four sequential steps in
the GA-biosynthetic pathway: 7b-hydroxylation, contraction of
ring B by oxidation at C-6, 3b-hydroxylation, and oxidation at C-7.
The GA precursors ent-7a-hydroxy[14C]kaurenoic acid, [14C]GA12-
aldehyde, and [14C]GA12 were also converted to [14C]GA14. In
addition, there is an indication that P450–1 may also be involved
in the formation of the kaurenolides and fujenoic acids, which are
by-products of GA biosynthesis in G. fujikuroi. Thus, P450–1 dis-
plays remarkable multifunctionality and may be responsible for the
formation of 12 products.
cytochrome P450 u ent-kaurenoid metabolism u GA14 synthase
G ibberellins (GAs) constitute a large family of tetracyclicditerpenoid carboxylic acids, some members of which func-
tion as growth hormones in higher plants, promoting processes
such as seed germination, stem elongation, f lower development,
and fruit growth (1). GAs were first identified as secondary
products of the fungus Gibberella fujikuroi (mating population C)
and are also produced by other fungal species (2–4). The early
steps of the GA-biosynthetic pathway from transgeranylgeranyl
diphosphate to GA12-aldehyde (Fig. 1) are identical for plants
and fungi, but the pathways diverge thereafter. The major end
product of the pathway in G. fujikuroi is gibberellic acid (GA3),
which is a minor GA component in most plant species.
Considerable progress has been made in isolating and char-
acterizing the genes of GA biosynthesis in plants (5). These
include genes encoding the membrane-associated cytochrome
P450-monooxygenases and soluble dioxygenases that catalyze,
respectively, intermediate and late steps of the pathway. Re-
cently, the genes involved in GA biosynthesis in G. fujikuroi were
found to be organized in a cluster containing at least seven genes
(ref. 6 and unpublished work). The identification of these genes
has provided the opportunity to study the fungal enzymes and
metabolic steps they catalyze, which had previously proved
difficult at the protein level (2). It has been possible to demon-
strate enzyme activities in vitro for only the early part of the
fungal GA pathway; these activities include the formation (7)
and metabolism (8) of the intermediate, ent-kaurene, the 7b-
hydroxylation of ent-kaurenoic acid (9), and the conversion of
GA12-aldehyde to GA14 (10). Each of these reactions after
ent-kaurene is catalyzed by microsomal monooxygenases with
the properties expected for cytochrome P450s.
Approximately 18 steps are required for the formation of GA3
from transgeranylgeranyl diphosphate (GGPP), yet the cluster
apparently contains only seven genes, one of which is GGPP
synthase (6). The limited number of genes suggests that either
not all of the genes have been identified or some genes encode
multifunctional enzymes. On the basis of amino acid sequence
similarities (ref. 6 and unpublished work), four of the seven genes
in the GA-biosynthesis cluster in G. fujikuroi appear to encode
cytochrome P450 monooxygenases. These genes are designated
P450–1, P450–2, P450–3, and P450–4; the P450–1 gene is closely
linked to P450–4 in the gene cluster, sharing the same promoter
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Fig. 1. Biosynthetic pathways to GAs and ent-kaurenoids in G. fujikuroi,
indicating the reactions we propose to be catalyzed by P450–1 (between
dotted lines). Thick arrows depict proposed major pathway from ent-
kaurenoic acid to GA14.






















sequence but being transcribed in the opposite direction (Fig. 2).
P450–1 is classified with P450–2 in the family CYP68 (6). In the
present study, we have used two methods to characterize its
function in the GA-biosynthetic pathway. We have shown by
disruption of P450–1 that the gene is involved in the conversion
of ent-kaurenoic acid. Furthermore, by expressing P450–1 in a G.
fujikuroi mutant lacking the entire gene cluster, we have dem-
onstrated that the gene product catalyzes four steps in the
metabolism of ent-kaurenoic acid to GA14. Our results also
indicate that P450–1 is responsible for the formation of ent-
kaurenoid-derived by-products of the GA-biosynthetic pathway.
Materials and Methods
Fungal Strains and Culture Conditions. The wild-type strain G.
fujikuroi IMI 58289 and the GA-defective mutant strain SG139
(11) were kindly provided by E. Cerda-Olmedo and J. Avalos
(University of Sevilla, Sevilla, Spain).
Bacterial Strains and Plasmids. For gene replacement experiments,
a 6.5-kb SalI fragment carrying the P450–1 gene was cloned into
pUC19 with a deleted SphI site (pUC19DSphI). An internal
1,519-bp fragment of this genomic SalI fragment was excised
with SphI and replaced by a 2.5-kb SphI fragment from the vector
pAN7–1 (12), carrying the hygromycin B resistance cassette. For
gene complementation, a 4-Kb HindIII fragment carrying the
whole P450–1 gene was cloned into pAN7–1 to give p450–1-GC.
Media and Culture Conditions. For DNA isolation, fungal strains
were grown in complete liquid medium optimized for Fusarium
spp (100 ml) (13) for 3 days at 28°C on a rotary shaker set at 200
rpm. The mycelium was harvested by filtration through a sterile
glass filter (G2, Schott Jena, Jena, Germany), washed with sterile
distilled water, frozen in liquid nitrogen, and lyophilized for 24 h.
The lyophilized mycelial tissue was ground into a fine powder.
For RNA isolation, the fungal strains were grown in 20% ICI
medium (14) for 48 h on a rotary shaker at 28°C. Cultures for
metabolism studies were established in 100% ICI medium (100
ml) for 4 days at 25°C on a rotary shaker, then subcultured into
40% ICI medium (100 ml) and, after 5 days, into 10% ICI
medium containing 1 mM AMO-1618 (Calbiochem) (100 ml).
Southern and Northern Blot Analysis. Genomic DNA was isolated
from lyophilized mycelium according to ref. 15. Plasmid DNA
was extracted by using Genomed columns following the manu-
facturer’s protocol (Genomed, Bad Oeynhausen, Germany).
After endonuclease digestion and electrophoresis, genomic
DNA was transferred onto Hybond N1 filters (Amersham
Pharmacia). The 32P-labeled probes were prepared by using the
random oligomer-primer method. Filters were hybridized at
65°C in 5 3 Denhardt’s solution (0.02% polyvinylpyrroli-
doney0.02% Ficolly0.02% BSA containing 5% dextran sulfate)
(16). Filters were washed at the hybridization temperature in 2 3
0.18 M NaCly10 mM phosphate, pH 7.4y1 mM EDTA
(SSPE)y0.1% SDS, and 1 3 SSPEy0.1% SDS.
RNA was isolated by using the RNAgents Total RNA Isola-
tion Kit (Promega). Northern blot hybridization was accom-
plished by the method of Church and Gilbert (17). The con-
served Botrytis cinerea actin gene (J. van Kan, personal
communication) was used as a control for RNA transfer.
Transformation of G. fujikuroi. Preparation of protoplasts and the
transformation procedure were carried out as described (18).
For gene replacement, 107 protoplasts (100 ml) of strain IMI
58289 were transformed with 10 mg of the SacI-digested gene
replacement vector P450–1-GR. For complementation of the
mutant strain SG139 with the intact P450–1 gene, protoplasts of
SG139 were transformed with 10 mg of the circular complemen-
tation vector P450–1-GC. For complementation of the restric-
tion enzyme-meditated integration-deletion mutant Gib1 (18)
carrying an additional nia-D mutation, a cotransformation was
performed by using 10 mg each of the vector P450–1-GK and the
vector pJ1, containing the intact G. fujikuroi niaD gene (19).
Transformed protoplasts were regenerated at 28°C in a com-
plete regeneration agar [0.7 M sucrosey0.05% yeast ex-
tracty0.1% (NH4)2SO4] containing 120 mgyml of hygromycin B
(Calbiochem) for 6–7 days or, in the case of cotransformation,
in a stabilized (0.8 M KCl) Czapex–Dox agar (Merck). Single
conidial cultures were established from hygromycin B-resistant
transformants and used for DNA isolation and Southern blot
analysis.
PCRs. G. fujikuroi genomic DNA (50 ng) was used as template for
amplification of the P450–1 gene in the wild type and transfor-
mants of strain SG139 with the P450–1 gene copy. The specific
primers (50 ng), which were synthesized by MWG–Biotech
(Munich), had the following sequences: forward (P450–1-F),
59-TAT ACA CCC TCG CCT GTG AGG G-39; reverse (P450–
1-R), 59-GTG AGG AGA CTT GCC GTC ATA GG-39. DNA
amplification was performed in 50-ml mixtures by using 2 units
of Taq DNA polymerase (Red-Taq, Sigma–Aldrich). PCR was
carried out for 36 cycles, each comprising 1 min denaturation at
94°C, 0.5 min annealing at 56°C, and 1.5 min synthesis at 72°C.
GA Analysis. For analysis of GA formation, strain IMI 58289 and
P450–1-disrupted mutants were cultivated in 100-ml Erlenmeyer
flasks containing 20 ml of 20% ICI medium. The cultures were
incubated for 7 days on a rotary shaker (200 rpm) at 28°C. GA
production was determined by HPLC (20) by using a Merck
HPLC system with a Lichrispher 100 RP18 column (5 mm; 250 3
4; Merck) or by TLC (18). Extracts of culture filtrates and
Fig. 2. The P450–1 locus in the GA gene cluster in G. fujikuroi. (A) Physical
map of the P450–1 ORF and surrounding genomic region. (B) Construction of
the gene replacement vector pP450–1-GR.






























mycelia were analyzed by combined GCyMS, as described
previously (18).
Incubations with Radiolabeled Substrates. ent-[14C4]kaurenoic
acid (specific radioactiv ity, 7.51 TBqzmol21), ent-7a-
hydroxy[14C4]kaurenoic acid (7.91 TBqzmol21), ent-6a,7a-
dihydroxy[14C4]kaurenoic acid (4.64 TBqzmol21), [14C4]GA12
(4.40 TBqzmol21), and [14C4]GA12-aldehyde (6.81 TBqzmol21)
were prepared from R-[2-14C]mevalonic acid (Amersham Phar-
macia) by using a cell-free system from pumpkin endosperm, as
described (21). Fungal cultures, grown in 40% ICI medium for
2 days at 28°C, were harvested and the mycelia washed with 0%
ICI medium (15). For experiments to characterize SG139 trans-
formants, mycelia were resuspended in 0% ICI and 1-ml aliquots
transferred to 25-ml sterile flasks containing 5 ml of the same
medium. The radiolabeled substrates (500 Bq per flask) or
ent-[17-2H]kaurenoic acid (20 mg to 4 mg per flask) were added
to the cultures in methanol (10–40 ml). After incubation on an
orbital shaker at 28°C for 2 days, cultures were filtered, and
filtrates were adjusted to pH 3.0 with 2 M HCl and partitioned
against ethyl acetate (3 3 equal volume). The combined organic
layers were evaporated under vacuum and the residue dissolved
in 20% methanolyH2O, pH 3.0. This solution was applied to a
C18 cartridge (SepPak, Waters) and the products eluted with
methanol and further analyzed by HPLC on a C18 column
(Symmetry, Waters) in a Waters 600 instrument by using a linear
gradient from 60 to 100% methanolyH2O, pH 3.0, over 15 min,
followed by 100% methanol for 15 min. The flow rate was 1
mlymin. Fractions (1 ml) were collected and the radioactivity
measured by liquid scintillation counting.
For incubations with P450–1-disrupted mutants, radiolabeled
substrates (2–4 kBq) were added in methanol (20–50 ml) to
5-day-old cultures in 10% ICI medium (5 ml) in sterile 50 ml
Falcon tubes. After incubation on an orbital shaker at 25°C for
3 days, the cultures were filtered and the filtrates extracted, as
described above. The mycelia were extracted with 10 ml of
methanol overnight, the extracts passed although silica gel (500
mg), which was eluted with a further 10 ml of methanol, and the
combined eluates taken to dryness in vacuo. The extracts were
analyzed by reverse-phase HPLC on a C18 Hypersil column
(25 3 0.46 cm) with on-line radioactivity monitoring (22);
culture extracts were eluted with a linear gradient of 20–100%
solvent B over 24 min at 1 mlzmin21, after which the column was
eluted with solvent B for a further 5 min (solvent A, 10%
methanol-water; solvent B, methanol, each containing 50
mlzliter21 acetic acid) and mycelial extracts, by using a gradient
of 75–100% B over 30 min followed by 30 min with B.
Microsomes were prepared from the mycelia of the SG139-T7
transformant as described previously (10) and incubated with
[14C4]GA12-aldehyde or [14C4]GA12 (10,000 dpm) in the pres-
ence of 1 mM NADPH and 5 mM FAD in a final volume of
100 ml. Products were extracted and analyzed by HPLC, as
described (10).
Results
Disruption of P450–1. The P450–1 gene was mapped between
P450–4 and P450–2 in the GA biosynthesis gene cluster (Fig.
2A). It was shown in a previous experiment (6) that replacement
of a central part of genes P450–1 and P450–2 led to the loss of
GA biosynthesis. To identify the biosynthetic steps in which the
P450–1 gene product is involved, the P450–1 locus was specif-
ically inactivated in the wild-type strain IMI 58289 by transfor-
mation with the linearized replacement vector, P450–1-GR,
containing the hygromycin resistance cassette as selection
marker (Fig. 2B). Among the 35 transformants generated, two,
DP450–1-T9 and -T35, failed to produce GAs when cultured in
a GA production medium. Southern blot analysis of genomic
DNA from these two transformants and the wild-type after
digestion with HindIII and PstI and probing with the 460-bp
P450–1 cDNA fragment (see Fig. 2) indicated clear differences
(Fig. 3A). The probe hybridized to a 4.0-kb HindIII and a 4.3-kb
PstI fragment from the wild-type strain and to 5.0-kb HindIII and
1.8-kb PstI fragments (because of an additional PstI-site in the
hygromycin cassette) from the transformants. These restriction
patterns were consistent with a double-crossover event between
the disruption vector and the P450–1 locus. Northern blot
analysis revealed two transcripts in DP450–1-T9 and -T35 of
altered lengths and lower abundance compared with the 1.6-kb
transcript from the wild type (Fig. 3B). The larger transcript may
be produced from reading through the terminator of the hygro-
mycin B resistance cassette, but the origin of the smaller
transcript is unclear.
The wild-type strain and T35 were grown under GA-inducing
conditions for 5 days, after which the culture filtrate and mycelia
were analyzed by full-scan GCyMS (Fig. 4A). The culture filtrate
from the wild type contained mainly GA3, with lower amounts
of GA13, and 7b,18-dihydroxykaurenolide. The isolactone of
GA3, which was also present, may be an artifact of the chroma-
tography. Strain DP450–1-T35 accumulated ent-kaurenoic acid
in the mycelium but not later intermediates in the culture filtrate
(Fig. 4A), so that the block appeared to be in the conversion of
ent-kaurenoic acid to ent-7a-hydroxykaurenoic acid. To confirm
this, we incubated T35 and the wild-type strain with 14C-labeled
ent-kaurenoic acid and GA12-aldehyde. The mutant strain T35
metabolized neither ent-kaurenoic acid, which accumulated in
the mycelia (Fig. 4B), nor GA12-aldehyde, which was extracted
from the culture filtrate (Fig. 4C). The wild-type strain converted
both intermediates efficiently to GA3. These results suggest that
the P450–1 enzyme catalyzes not only the conversion of ent-
kaurenoic acid but also at least one subsequent oxidative step in
the pathway.
Functional Analysis of P450–1. To define precisely the metabolic
steps catalyzed by the P450–1 enzyme, we transformed the
GA-deficient mutant strain SG139 with the gene complemen-
Fig. 3. Molecular analysis of P450–1 replacement mutants (A) Southern blot
analysis of G. fujikuroi strains IMI 58289 (wild type), SG139 (mutant lacking
GA-biosynthesis gene cluster), and gene-disruption mutants DP450–1-T9 and
DP450–1-T35. Genomic DNA from each strain was digested with either HindIII
(lanes 1–3) or PstI (lanes 4–6), and the blots were probed with P450–1 cDNA.
The size standards are indicated in kilobases. (B) Northern blot analysis of the
wild-type strain IMI 58289 and the replacement mutants T9 and T35. The blot
was probed with the P450–1 cDNA and the Botrytis cinerea actin gene
(loading control)






















tation vector, pP450–1-GC, carrying the whole wild-type P450–1
gene. Mutant SG139, which was produced by UV treatment (11),
lacks the entire GA gene cluster, as demonstrated by Southern
blot (see Fig. 3A) and PCR analysis (data not shown). In an
additional experiment, the GA-deficient mutant Gib1, which
also lacks the GA gene cluster as part of an '300-Kb fragment
that was lost from chromosome IV after restriction enzyme-
meditated integration (18), was also transformed with pP450–
1-GC. Of 45 transformants analyzed, 38 contained the expected
2,310-bp PCR fragment between primers P450–1-F and P450–
1-R. To confirm that the gene is expressed in the transformants,
Northern blot analysis was performed on five PCR-positive lines
derived from SG139 (SG139-T7, -T8, -T10, -T15, and -T32), one
transformant that did not reveal a PCR fragment of the expected
size (SG139-T20), and one PCR-positive line (Gib1-T6) derived
from Gib1. IMI58289, SG139, and Gib1 were also analyzed as
controls. As shown in Fig. 5, P450–1 is expressed in all PCR-
positive transformants tested and in the wild-type strain. No
transcript for P450–1 was present in the deletion mutants SG139
and Gib1 or in SG139-T20.
Three SG139 transformants (SG139-T7, SG139-T10, and
SG139-T32) and one transformant of Gib1 (Gib1-T6) were incu-
bated for 2 days with ent-[14C]kaurenoic acid, ent-7a-
hydroxy[14C]kaurenoic acid, [14C]GA12-aldehyde, and [14C]GA12
(not with Gib1-T6) under GA-inducing conditions, and the prod-
ucts were analyzed by HPLC (shown for SG139-T32 in Fig. 6). Each
transformant metabolized all four substrates, the major product in
each case having a retention time (Rt) of 13–14 min. The main
radiolabeled compound in this fraction was identified by GCyMS
as [14C]GA14 (Table 1). After shorter (2- to 6-h) incubations of
SG139-T32 with ent-[14C]kaurenoic acid, small amounts of ent-7a-
hydroxy[14C]kaurenoic acid (Rt, 16 min) and 7b,18-
dihydroxy[14C]kaurenolide (Rt, 13 min) were identified, whereas
no other product besides [14C]GA14 could be detected by GCyMS
after incubations with ent-7a-hydroxy[14C]kaurenoic acid or
[14C]GA12-aldehyde. Neither GA12-aldehyde nor GA14-aldehyde,
Fig. 4. Characterization of gene disruption mutant DP450–1-T35. (A) Total
ion currents from GCyMS analyses of extracts of culture filtrates and mycelia
from G. fujikuroi strains IMI 58289 (wild type) and DP450–1-T35. (B and C)
HPLC radiochromatograms of extracts from the culture filtrates and mycelia
after incubation of ent-[14C4]kaurenoic acid (B) and [14C4]GA12-aldehyde (cul-
ture filtrate only) (C) with IMI58289 and DP450–1-T35.
Fig. 5. Northern blot analysis of the G. fujikuroi deletion mutants SG139 and
Gib1, and strains transformed with the vector P450–1-GC carrying the com-
plete P450–1 gene copy. The blot was probed with the P450–1 cDNA and the
Botrytis cinerea actin gene (loading control)
Fig. 6. HPLC-radioactivity profiles of total extracts from incubations of
ent-[14C4]kaurenoic acid, ent-7a-hydroxy[14C4]kaurenoic acid, [14C4]GA12-
aldehyde, or [14C4]GA12 with the G. fujikuroi wild-type strain IMI 58289,
deletion mutant SG139, and the P450–1 transformant SG139-T32. Retention
times for ent-kaurenoic acid, ent-7a-hydroxykaurenoic acid, GA12-aldehyde,
and GA12 are 22, 16, 18, and 17 min, respectively. HPLC and incubation
conditions were as described in Materials and Methods, except for ent-
kaurenoic acid with SG139-T32, for which the incubation time was 4 h.






























which has been demonstrated to be an intermediate on the main
pathway to GA3 in G. fujikuroi (23), accumulated in any of the
incubations. The wild-type IMI 58289 strain, from which SG139
was obtained, converted ent-[14C]kaurenoic acid, ent-7a-
hydroxy[14C]kaurenoic acid, and [14C]GA12-aldehyde to products
that are more polar than GA14, including GA3 (Rt, 5–6 min),
whereas the major products from [14C]GA12 eluted with a Rt of
13–15 min. None of the substrates were metabolized by the deletion
mutants SG139 (Fig. 6) and Gib1 (not shown).
When milligram amounts of ent-[2H]kaurenoic acid were
incubated with the SG139-T7 transformant, 41% of substrate
remained, and [2H]GA14 was produced as the main product
(45%). The intermediates ent-7a-hydroxy[2H]kaurenoic acid
and [2H]GA12 were detected by GCyMS as minor products,
together with 2H-labeled 7b-hydroxykaurenolide, 7b,18-
dihydroxykaurenolide, 3b,7b-dihydroxykaurenolide, and fuje-
noic acid (Table 1). The P450–1 transformants were also incu-
bated with ent-6a,7a-dihydroxy[14C]kaurenoic acid and the
products separated by TLC. In each case, there was complete
conversion to give a radioactive band at Rf 0.25–0.38, which was
shown by GCyMS for SG139-T7 to contain 14C-labeled fujenoic
acid and fujenoic triacid (Table 1). After incubation with the
deletion mutants, a single band of radioactivity was obtained at
the same Rf (0.62–0.75) as the substrate, indicating there had
been no conversion.
The metabolism of [14C]GA12-aldehyde and [14C]GA12 was
investigated also with isolated microsomes from SG139-T7 my-
celia. In the presence of 1 mM NADPH and 5 mM FAD,
[14C]GA12-aldehyde was efficiently converted to [14C]GA14
(60%) plus smaller amounts of [14C]GA12 (15%), whereas
[14C]GA12 remained unchanged under these conditions.
Discussion
We have used two methods to determine the function of the
cytochrome P450 monooxygenase encoded by P450–1, one of a
cluster of seven genes involved in GA biosynthesis in G. fujikuroi.
First, specific disruption of this gene in a GA-producing strain of
the fungus indicated that the encoded enzyme catalyzed the
7b-hydroxylation of ent-kaurenoic acid. However, we showed
that at least one later step in the pathway was also affected by
disrupting P450–1. Second, we examined the function of P450–1
in the absence of the other GA-biosynthetic enzymes by express-
ing the gene in G. fujikuroi mutants that lacked the GA-
biosynthesis gene cluster. By this means, we could demonstrate
that the enzyme converts ent-kaurenoic acid to GA14 and thus
catalyzes four steps in the GA-biosynthetic pathway: hydroxy-
lation at C-7, oxidation at C-6 resulting in contraction of ring B
(24, 25), 3b-hydroxylation, and finally oxidation at C-7 (Fig. 1).
Intermediates in this sequence, ent-7a-hydroxykaurenoic acid
and GA12-aldehyde, as well as GA12, which is not thought to be
a normal precursor of 3b-hydroxylated GAs (26), were con-
verted efficiently by the enzyme to GA14. Even when ent-
kaurenoic acid was applied at very high concentrations, GA14
was the predominant product, and only low amounts of ent-7a-
hydroxykaurenoic acid and GA12 were found in the culture
medium. This result suggests that the first step in the reaction
sequence may limit the overall reaction rate, although uptake of
the substrates into the cell may be the limiting factor.
Microsomes from G. fujikuroi have been shown to catalyze the
reaction sequence from ent-kaurenoic acid to GA12 and GA14 (9,
10, 27). However, microsomal preparations failed to convert
GA12 to GA14 by 3b-hydroxylation, regardless of whether they
were prepared from a wild-type strain (10) or from the P450–1
transformants (this work). This apparent inconsistency between
the experiments by using intact cultures of the P450–1 transfor-
mants and those with microsomal preparations could be ex-
plained if GA12 is a relatively poor substrate for 3b-
hydroxylation. If GA12 is converted to GA14 at a slow rate, this
reaction could occur only in cultures of the P450–1 transformant,
where the substrate is in contact with high levels of enzyme for
long periods of time in the absence of competing enzyme
activities. Thus, the major pathway to GA14 is presumably via
GA14-aldehyde (23), which was not detected as an intermediate
in the present study. In our experiments, the wild-type strain
converted GA12 to nonpolar products, consistent with the results
of Bearder et al. (28), who found that GA12 is metabolized mainly
to the non-3b-hydroxylated GA, GA9. The small amount of GA3
formed from GA12 may be the result of the low rate of
3b-hydroxylation.
We provide evidence to suggest that P450–1, as well as
catalyzing reactions of the GA-biosynthetic pathway, may be
involved in two branch pathways, those from ent-kaurenoic acid
to the kaurenolides and those from ent-7a-hydroxykaurenoic
acid to seco-ring B products (3) (Fig. 1). We detected 7b-
hydroxy-, 3b,7b-dihydroxy-, and 7b,18-dihydroxykaurenolides
together with fujenoic acid as products after incubations of
ent-kaurenoic acid with cultures of the P450–1 transformants,
whereas the deletion mutants lacking the P450–1 gene failed to
metabolize ent-kaurenoic acid or ent-7a-hydroxykaurenoic acid.
Furthermore, the transformants formed fujenoic acid and fuje-
noic triacid from ent-6a,7a-dihydroxykaurenoic acid, whereas
the deletion mutants did not metabolize this intermediate.
ent-6a,7a-dihydroxykaurenoic acid, which was postulated as the
precursor of the seco-ring B products (29), has been shown to be
formed together with GA12-aldehyde in cell-free preparations
from pumpkin endosperm by oxidation of ent-7a-hydroxykau-
renoic acid on C-6 (25). Full confirmation for the involvement
of P450–1 in the branch pathways will require demonstration of
each metabolic step in the P450–1 transformants and its absence
in the disruption or deletion mutants. However, the seven
reactions required for the branch pathways (Fig. 1), involving
oxidation on C-3, C-6, C-7, and C-18, are consistent with the
demonstrated activities of P450–1 for the conversion of ent-
kaurenoic acid to GA14.
Sequential oxidations at a single carbon atom that are medi-
ated by cytochrome P450s have been described as, for example,
in the loss of C-14 in steroid biosynthesis (30) and the three-step
oxidation of ent-kaurene to ent-kaurenoic acid in G. fujikuroi (8).
However, the reactions catalyzed by P450–1 involve oxidations
Table 1. Products identified by GCyMS from incubations of
isotopically labeled intermediates with mutant strain



















The mass spectrometric data are provided as Table 2, which is published as
supplemental data on the PNAS web site, www.pnas.org.
*Total extracts of culture filtrates were analyzed by GCyMS. Otherwise, ex-
tracts were separated by HPLC, and fractions containing radioactivity were
analyzed.






















at four different carbon atoms, C-6, C-7, C-3, and C-18, most of
which are nonadjacent. Oxidation at multiple sites by a single
P450 enzyme has been reported for monooxygenases involved in
mammalian steroid biosynthesis as, for example, in the 11b- and
18-hydroxylation of 11-deoxycorticosterone by porcine adreno-
cortical cytochrome P450 (11b) (31) and 11b-, 18-, and 19-
hydroxylations of the same steroid by rat cytochrome P450 (11b)
(32). Furthermore, in the fungus Curvularia lunata, 11-
deoxycortisol is hydroxylated at positions 11b and 14a by the
same P450 monooxygenase (33). P450–1 contains a single
heme-binding motif so that all reactions catalyzed, which include
oxidations at seemingly remote carbon centers, must occur at the
same active site. However, depending on conformation, the sites
oxidized by P450–1, for example C-3b and C-7 in GA12-
aldehyde, are sufficiently close that little change in substrate-
binding orientation may be required for either reaction to take
place. Differences in the requirement for FAD for GA12-
aldehyde 7-oxidase and 3b-hydroxylase activities (10) might
suggest interaction of the P450–1 heme with different electron
transport proteins for these two reactions. A small change in the
binding orientation of 7b-hydroxykaurenolide relative to that of
ent-7a-hydroxykaurenoic acid would allow the former substrate,
but not the latter, to be hydroxylated at C-18 or C-3b.
Analysis of its secondary structure indicates that P450–1, in
common with most eukaryotic cytochrome P450s, contains a
single membrane-spanning domain at its N terminus. However,
the enzyme is apparently loosely bound to the microsomal
fraction, as it can be easily solubilized in the presence of high salt
concentrations (9).
We have recently become aware of parallel work showing that
barley and Arabidopsis contain cytochrome P450 monoxygenases
with catalytic activity similar to that of P450–1 (34). The plant
enzymes, which belong to the CYP88A subfamily, convert
ent-kaurenoic acid to GA12. There must, however, be important
differences between the fungal and plant enzymes because in
plants, 3b-hydroxylation is catalyzed by 2-oxoglutarate-
dependent dioxygenases and, in most cases, occurs late in the
pathway, after C-20 has been removed (see ref. 5). The plant
enzymes responsible for GA12 synthesis are not apparently
capable of 3b-hydroxylation.
The involvement of dioxygenases in GA biosynthesis in plants
has been shown for oxidation at C-20, C-2b, C-3b, and, in
pumpkin, C-7. Oxidation at C-20, resulting in the loss of this C
atom, occurs also in G. fujikuroi. However, as no dioxygenase
genes have been identified within the GA-biosynthesis gene
cluster of the fungus, it seems likely that the 20-oxidase is a
different type of enzyme in G. fujikuroi, most probably a
cytochrome P450. The conversion of GA12-aldehyde to GA12
(7-oxidation) in pumpkin seed can be catalyzed by either mono-
oxygenase or dioxygenase activities (35, 36), but it is not known
whether the dioxygenase is of more general significance. In
Arabidopsis, there are no candidate dioxygenases GA 7-oxidase
genes (37), so it appears likely that this activity is caused solely
by a monooxygenase.
Research of GA biosynthesis has reached an exciting stage in
plants and in G. fujikuroi. As more genes and enzymes are
characterized, it is becoming clear that very significant differ-
ences exist in the genetics and biochemistry of GA biosynthesis
in plants and fungus. For example, they differ in the organization
of the genes, in the nature and substrate specificities of the
enzymes, and in the mechanisms of regulation. For G. fujikuroi,
most of the genes are now available, allowing new opportunities
for detailed studies of their regulation. Furthermore, mutants
lacking the GA-biosynthesis gene cluster provide a highly effi-
cient and convenient expression system for the preparation of
enzymes for studies of function and structure.
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